SCHEMBL30176397

SCHEMBL30176397

COCOc1ccc(Br)c(I)c1

nearest known ligand 0.35

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 1/20 0.35
▸ FYN P06241 4/20 0.33
▸ MAPT P10636 1/20 0.33
▸ KDM4E B2RXH2 1/20 0.32
▸ ALDH1A1 P00352 1/20 0.32
▸ MEN1 O00255 1/20 0.31
▸ KMT2A Q03164 1/20 0.31
▸ MMP2 P08253 1/20 0.31
▸ MMP3 P08254 1/20 0.31
▸ MMP9 P14780 1/20 0.31
▸ MMP14 P50281 1/20 0.31
▸ FFAR1 O14842 1/20 0.30
▸ APP P05067 4/20 0.30
▸ MAOB P27338 1/20 0.30
▸ ACHE P22303 1/20 0.30
▸ BACE1 P56817 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23887132 1.00 SMN1; SMN2 (0.35) SMN1; SMN2FYNMAPTKDM4EALDH1A1
SCHEMBL30708510 0.85 FYN (0.36) SMN1; SMN2FYNMAPTKDM4EALDH1A1
SCHEMBL7595839 0.82 FYN (0.35) FYNMMP2MMP3MMP9MMP14
SCHEMBL6322208 0.81 NQO1 (0.50) MAPTKDM4EALDH1A1MEN1KMT2A
SCHEMBL614591 0.79 PIK3CD (0.40) SMN1; SMN2FYNMAPTKDM4EALDH1A1
SCHEMBL1527596 0.79 SMN1; SMN2 (0.53) SMN1; SMN2MAPTALDH1A1MEN1KMT2A
SCHEMBL2803033 0.78 CA12 (0.43) SMN1; SMN2MAPTKDM4EALDH1A1MEN1
SCHEMBL13285991 0.78 SMN1; SMN2 (0.41) SMN1; SMN2FYNMAPTFFAR1MAOB
SCHEMBL2176515 0.78 FYN (0.45) FYNMAPTKDM4EALDH1A1MEN1
SCHEMBL2171833 0.78 EGFR (0.43) SMN1; SMN2FYNMAPTKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115916749-A Substituted 5-hydroxyindole compounds as alpha-1 antitrypsin modulators 弗特克斯药品有限公司 2023-04-04 — — CN disclosed
EP-4126817-A1 SUBSTITUTED 5-HYDROXYINDOLE COMPOUNDS AS MODULATORS OF ALPHA-1 ANTITRYPSIN Vertex Pharmaceuticals Incorporated (US) 2023-02-08 — — EP disclosed
Send feedback